Your browser doesn't support javascript.
loading
Changes in dementia diagnoses in Sweden during the COVID-19 pandemic.
Axenhus, Michael; Schedin-Weiss, Sophia; Tjernberg, Lars; Wimo, Anders; Eriksdotter, Maria; Bucht, Gustaf; Winblad, Bengt.
Afiliación
  • Axenhus M; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden. michael.axenhus.2@ki.se.
  • Schedin-Weiss S; Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden. michael.axenhus.2@ki.se.
  • Tjernberg L; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden.
  • Wimo A; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden.
  • Eriksdotter M; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden.
  • Bucht G; The primary care of Hudiksvall-Nordanstig, the Region of Gävleborg, Gävle, Sweden.
  • Winblad B; Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden.
BMC Geriatr ; 22(1): 365, 2022 04 26.
Article en En | MEDLINE | ID: mdl-35473668
INTRODUCTION: The COVID-19 pandemic has caused large disruptions to healthcare systems. Refocus on COVID-19 related care might have contributed to indirect effects on other healthcare areas. Care focused on acute conditions have been negatively affected although research into the effects on chronic and care intensive patient groups such as patients with dementia diseases is lacking. In this study we evaluated dementia diagnosis trends in Sweden during 2015-2020 according to International Classification of Disease version 10 coding of common dementia diseases. METHODS: Regional and national statistics in the form of International Classification of Disease version 10 coding, COVID-19 incidence, mortality data, and population census data were collected from the National Institute of Health and Welfare. Logistic regression analysis was performed to identify trends of dementia diagnosis during 2015-2020. Correlation test was performed between COVID-19 incidence, mortality rates, and dementia coding. RESULTS: Dementia diagnosis incidence has been declining since 2015 and further decline was noted in many regions in Sweden during 2020. As COVID-19 incidence increased, fewer cases of dementia were diagnosed, a decrease that differentially impacted women and those who were advanced in age. CONCLUSIONS: Dementia diagnosis incidence in Sweden has been on a decline since 2015. The COVID-19 pandemic caused a further larger decline in dementia diagnosis incidence during 2020. COVID-19 incidence, but not mortality, was associated with decrease in dementia diagnosis incidence. There might be a large number of undiagnosed patients with dementia and healthcare reforms should be enacted to address this. Women and elderly are particularly vulnerable groups.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Demencia / COVID-19 Tipo de estudio: Diagnostic_studies / Incidence_studies / Prognostic_studies Límite: Aged / Female / Humans País/Región como asunto: Europa Idioma: En Revista: BMC Geriatr Asunto de la revista: GERIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Demencia / COVID-19 Tipo de estudio: Diagnostic_studies / Incidence_studies / Prognostic_studies Límite: Aged / Female / Humans País/Región como asunto: Europa Idioma: En Revista: BMC Geriatr Asunto de la revista: GERIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Suecia